Dai-ichi Life Holdings (8750) AI Stock Analysis

• Market Cap: $4.00T
• Dividend Yield: 3.53%
• Average Volume (3M): 8.51M
• Price to Earnings (P/E): 11.9
• Beta (1Y): 1.25
• Revenue Growth: -8.02%
• EPS Growth: 5.21%
• Country: JP
• Employees: 59,495
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Life
• EPS (TTM): 45.49
• Shares Outstanding: 3,700,761,200
• 10 Day Avg. Volume: 9,863,640
• 30 Day Avg. Volume: 8,511,503
• PEG Ratio: 0.24
• Price to Book (P/B): 1.21
• Price to Sales (P/S): 0.45
• P/FCF Ratio: 7.88
• Enterprise Value/Market Cap: 1.75
• Enterprise Value/Revenue: 0.83
• Enterprise Value/Gross Profit: 0.83
• Enterprise Value/Ebitda: 13.93
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 69 Neutral
• Price Target: ¥1,360.00 ▲(9.99% Upside)

Dai-ichi Life Holdings scores a 69, driven primarily by its strong technical indicators and reasonable valuation. The financial performance is mixed, with improved profitability but challenges in revenue growth and cash flow generation. The stock's overbought technical indicators suggest caution, but the overall outlook remains positive due to its solid balance sheet and fair valuation.

Dai-ichi Life Holdings Business Overview & Revenue Model

Company Description

Dai-ichi Life Holdings, Inc., through its subsidiaries, provides life insurance products in Japan, the United States, and internationally. It operates through Domestic Life Insurance Business, Overseas Insurance Business, and Other Business segments. The company offers individual life insurance and annuities, non-participating single premium whole life insurance, financial insurance and annuities, and group annuities. It also provides investment management products and services to individuals and institutional clients. The company was formerly known as The Dai-Ichi Life Insurance Company, Limited and changed its name to Dai-ichi Life Holdings, Inc. in October 2016. Dai-ichi Life Holdings, Inc. was incorporated in 1902 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Dai-ichi Life Holdings generates revenue primarily through the sale of life insurance products, including traditional whole life, term life, and endowment policies. The company earns premiums from policyholders, which constitute a significant portion of its income. Additionally, it generates revenue from investment income derived from the premiums collected, as these funds are invested in various assets such as stocks, bonds, and real estate. Annuity products also contribute to its revenue, providing a steady stream of income over time. Furthermore, the company has established partnerships with various financial institutions, allowing it to offer a broader array of products and reach a larger customer base, which enhances its earnings potential. The growing focus on overseas markets and digital transformation initiatives also play a crucial role in diversifying and increasing its revenue streams.

Dai-ichi Life Holdings Financial Statement Overview

Summary

Dai-ichi Life Holdings shows a mixed financial performance. Despite a revenue decline of -7.62%, profitability has improved with a net profit margin of 4.86%. The balance sheet is strong with a debt-to-equity ratio of 0.34 and a return on equity of 12.38%. Cash flow analysis reveals challenges in operational cash generation, but the company effectively converts profits into free cash flow.

Income Statement

Dai-ichi Life Holdings shows a mixed performance in its income statement. The company has experienced a decline in revenue growth rate of -7.62% in the latest year, which is concerning. However, the net profit margin has improved to 4.86%, indicating better profitability. The EBIT and EBITDA margins are stable at around 6.91%, reflecting consistent operational efficiency. Despite the revenue decline, the company has managed to maintain profitability, which is a positive sign.

Balance Sheet

The balance sheet of Dai-ichi Life Holdings is relatively strong with a debt-to-equity ratio of 0.34, indicating moderate leverage. The return on equity has improved to 12.38%, showing efficient use of equity to generate profits. The equity ratio stands at 4.98%, suggesting a stable capital structure. Overall, the company maintains a healthy balance sheet with manageable debt levels and strong equity returns.

Cash Flow

Cash flow analysis reveals some challenges for Dai-ichi Life Holdings. The operating cash flow to net income ratio is 0.33, indicating that cash generation from operations is lower compared to net income. However, the free cash flow to net income ratio is strong at 0.90, suggesting that the company is effectively converting its profits into free cash flow. The free cash flow growth rate is not meaningful due to previous negative values, but the current positive free cash flow is a positive indicator.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	8.48T	8.80T	10.49T	8.41T	7.86T	7.57T
Gross Profit	8.48T	8.80T	10.49T	8.41T	7.86T	7.57T
EBITDA	502.89B	611.61B	565.73B	395.01B	591.04B	589.33B
Net Income	337.54B	429.61B	320.76B	173.74B	409.35B	363.78B
Balance Sheet
Total Assets	68.59T	69.59T	67.54T	61.58T	65.88T	63.59T
Cash, Cash Equivalents and Short-Term Investments	0.00	1.89T	2.06T	1.62T	2.18T	1.88T
Total Debt	1.14T	1.19T	975.29B	949.67B	870.38B	899.77B
Total Liabilities	65.01T	66.12T	63.66T	58.71T	61.47T	58.79T
Stockholders Equity	3.58T	3.47T	3.88T	2.66T	4.41T	4.81T
Cash Flow
Free Cash Flow	0.00	532.46B	946.24B	-250.35B	-561.54B	-118.07B
Operating Cash Flow	0.00	592.58B	997.38B	-132.49B	-462.08B	-79.90B
Investing Cash Flow	0.00	-968.03B	-644.92B	117.10B	940.87B	615.10B
Financing Cash Flow	0.00	-73.57B	-145.76B	-325.45B	-180.71B	65.59B

Dai-ichi Life Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1236.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8750, the sentiment is Positive. The current price of 1236.5 is above the 20-day moving average (MA) of 1134.80, above the 50-day MA of 1141.82, and above the 200-day MA of 1093.83, indicating a bullish trend. The MACD of 29.64 indicates Negative momentum. The RSI at 69.79 is Neutral, neither overbought nor oversold. The STOCH value of 75.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:8750.

Dai-ichi Life Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8630	76 Outperform	$4.29T	18.55	―	3.32%	11.37%	27.90%
7181	70 Outperform	¥1.44T	11.13	―	2.75%	-21.38%	58.03%
8750	69 Neutral	$4.00T	11.85	10.61%	3.53%	-8.02%	5.21%
8725	69 Neutral	$5.02T	6.86	16.44%	2.97%	23.01%	2.59%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
7182	67 Neutral	$6.22T	14.83	4.49%	3.30%	2.17%	9.55%
8795	61 Neutral	¥1.73T	13.39	8.83%	3.06%	-1.96%	10.32%

Dai-ichi Life Holdings Corporate Events

Dai-ichi Life Completes New Share Issuance for Stock Compensation

Dai-ichi Life Holdings has completed the payment related to the issuance of new shares as part of a performance-linked stock compensation scheme. This move, approved by the Board of Directors, involves issuing 280,400 shares of common stock, aimed at aligning the interests of the company’s directors and executive officers with its performance, potentially impacting its market positioning and stakeholder engagement.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Holdings Reports Mixed Financial Results

Dai-ichi Life Holdings, Inc. is a prominent company in the insurance sector, primarily engaged in life insurance services and financial planning solutions. The company is listed on the Tokyo Stock Exchange and is known for its comprehensive insurance offerings and financial stability.

Dai-ichi Life Holdings Boosts Assets with Reinsurance Deal

Dai-ichi Life Holdings announced the completion of a reinsurance transaction by its subsidiary, Protective Life Corporation, which has resulted in a significant increase in the company’s consolidated total assets by USD 6.7 billion. This transaction reflects a 25.6% increase in consolidated net assets as of March 2024, highlighting the company’s strategic efforts to enhance its financial position and asset base.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Holdings Revises Earnings and Dividend Forecasts Upward

Dai-ichi Life Holdings has revised its consolidated earnings and dividend forecasts for the fiscal year ending March 31, 2026, citing increased gains on sales of securities due to robust stock prices. The company expects higher ordinary revenues, profits, and net income, leading to an increase in the year-end dividend forecast from 24 yen to 27 yen per share, reflecting a positive outlook for stakeholders.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Neo First Life Insurance Reports Six-Month Financial Results

The Neo First Life Insurance Company, a subsidiary of Dai-ichi Life Holdings, reported its financial results for the six months ending September 30, 2025. The announcement provides detailed insights into the company’s financial health, including investment results and solvency margin ratio, which are crucial for stakeholders to assess the company’s stability and performance.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Frontier Life Announces Six-Month Financial Results

Dai-ichi Frontier Life Insurance Co., Ltd., a subsidiary of Dai-ichi Life Holdings, has announced its financial results for the six months ending September 30, 2025. The release provides detailed insights into the company’s financial performance, including investment results, balance sheet, and profit breakdown, which are crucial for stakeholders to assess the company’s financial health and strategic positioning in the insurance market.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Holdings Reports Six-Month Financial Results

Dai-ichi Life Holdings announced its financial results for the six months ending September 30, 2025, highlighting key financial metrics and performance indicators. The release provides insights into the company’s operational efficiency and financial health, which are crucial for stakeholders assessing the company’s market positioning and future prospects.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Holdings Reports Mixed Financial Results for H1 2025

Dai-ichi Life Holdings reported a mixed financial performance for the six months ending September 30, 2025, with a decline in group fundamental profit by 10.7% compared to the previous year. Despite this, the company saw a positive increase in its solvency margin ratio, indicating a stronger financial position, which may reassure stakeholders about its long-term stability.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Holdings Reports Decline in Semi-Annual Profits and Revises Dividend Forecasts

Dai-ichi Life Holdings reported a decrease in ordinary revenues and profits for the six months ended September 30, 2025, compared to the same period in the previous year. Despite a challenging financial performance, the company announced a revision in its dividend forecasts and earnings projections for the fiscal year ending March 31, 2026, indicating strategic adjustments to enhance shareholder value and stabilize its financial outlook.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Holdings Reports No Share Repurchases in October 2025

Dai-ichi Life Holdings announced that it did not repurchase any of its shares in October 2025, despite having a board-approved plan to buy back up to 200 million shares by May 2026. This lack of repurchase activity could indicate a strategic decision to hold off on buybacks, potentially affecting shareholder expectations and market perceptions.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Holdings Expands Stake in Wealth Management, Inc.

Dai-ichi Life Holdings, Inc. announced its decision to acquire a substantial shareholding in Wealth Management, Inc., amounting to 28.47% of total voting rights. This strategic acquisition is expected to enhance Dai-ichi Life’s market position and expand its influence in the wealth management sector, potentially impacting its operations and stakeholder interests.

The most recent analyst rating on (JP:8750) stock is a Hold with a Yen1196.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Holdings Announces Share Repurchase Program

Dai-ichi Life Holdings announced the repurchase of 5,618,400 shares of its common stock for approximately 6.9 billion yen, conducted through open-market transactions in September 2025. This move is part of a broader share buyback program authorized by the board, which allows for the repurchase of up to 200 million shares, highlighting the company’s strategy to enhance shareholder value and optimize capital allocation.

The most recent analyst rating on (JP:8750) stock is a Buy with a Yen1380.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Holdings Announces Share Repurchase Update

Dai-ichi Life Holdings announced the repurchase of 9,040,700 shares of its common stock at an aggregate purchase price of 11,138,624,100 yen during August 2025. This move is part of a broader strategy approved by the board of directors to repurchase up to 200 million shares, aiming to enhance shareholder value and optimize the capital structure.

The most recent analyst rating on (JP:8750) stock is a Buy with a Yen1380.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.

Dai-ichi Life Rebrands Australian Subsidiary

Dai-ichi Life Holdings has announced a trade name change for its Australian subsidiary from TAL Dai-ichi Life Australia Pty Ltd to TAL Daiichi Life Australia Pty Ltd. This change aligns with the company’s broader strategy to rebrand as Daiichi Life Group, Inc., effective April 2026, and reflects a cohesive identity across its global operations.

The most recent analyst rating on (JP:8750) stock is a Buy with a Yen1380.00 price target. To see the full list of analyst forecasts on Dai-ichi Life Holdings stock, see the JP:8750 Stock Forecast page.